Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
October-2015 Volume 12 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2015 Volume 12 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis

  • Authors:
    • Xianqiong Gong
    • Rui Duan
    • Jin‑E Ao
    • Qing Ai
    • Pu Ge
    • Ling Lin
    • Li Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Liver Diseases, Hepatology Center, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian 361000, P.R. China, Department of General Surgery, The First People's Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China, Department of Pathology, The First People's Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China, Department of Physiology, Chongqing Medical University, Chongqing 400016, P.R. China, Department of Pathophysiology, Chongqing Medical University, Chongqing 400016, P.R. China
  • Pages: 6384-6390
    |
    Published online on: August 10, 2015
       https://doi.org/10.3892/mmr.2015.4206
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Metformin is a widely‑used antidiabetic drug with hypoglycemic activity and previously described anti‑inflammatory properties. Previous studies have demonstrated that metformin attenuates endotoxic hepatitis, however the mechanisms remain unclear. Inflammation and coagulation are closely associated pathological processes, therefore the potential effects of metformin on key steps in activation of the coagulation system were further investigated in endotoxic hepatitis induced by lipopolysaccharide/D‑galactosamine (LPS/D‑Gal). The current study demonstrated that treatment with metformin significantly suppressed the upregulation of tissue factor and plasminogen activator inhibitor‑1 in LPS/D‑Gal‑exposed mice. In addition, a reduction in the expression of interleukin 6 and inhibition of nuclear translocation of nuclear factor‑κB were observed. These data indicate that the LPS/D‑Gal‑induced elevation of the stable protein level of hypoxia inducible factor 1α, the mRNA level of erythropoietin, vascular endothelial growth factor and matrix metalloproteinase‑3, and the hepatic level of lactic acid were also suppressed by metformin. The current study indicates that the suppressive effects of metformin on inflammation‑induced coagulation may be an additional mechanism underlying the hepatoprotective effects of metformin in mice with LPS/D‑Gal‑induced fulminant hepatitis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Schiødt FV and Lee WM: Fulminant liver disease. Clin Liver Dis. 7:331–349. vi2003. View Article : Google Scholar : PubMed/NCBI

2 

Bernal W, Auzinger G, Dhawan A and Wendon J: Acute liver failure. Lancet. 376:190–201. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Tsutsui H, Adachi K, Seki E and Nakanishi K: Cytokine-induced inflammatory liver injuries. Curr Mol Med. 3:545–559. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Hatano E: Tumor necrosis factor signaling in hepatocyte apoptosis. J Gastroenterol Hepatol. 22(Suppl 1): S43–S44. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Kim SJ and Lee SM: NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: Role of heme oxygenase-1. Free Radic Biol Med. 65:997–1004. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Li Y, Xu Z, Yu Y, Yuan H, Xu H, Zhu Q, Wang C and Shi X: The vagus nerve attenuates fulminant hepatitis by activating the Src kinase in Kuppfer cells. Scand J Immunol. 79:105–112. 2014. View Article : Google Scholar

7 

Levi M, Schultz M and van der Poll T: Sepsis and thrombosis. Semin Thromb Hemost. 39:559–566. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Aksu K, Donmez A and Keser G: Inflammation-induced thrombosis: Mechanisms, disease associations and management. Curr Pharm Des. 18:1478–1493. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Semeraro N, Ammollo CT, Semeraro F and Colucci M: Sepsis, thrombosis and organ dysfunction. Thromb Res. 129:290–295. 2012. View Article : Google Scholar

10 

O'Brien M: The reciprocal relationship between inflammation and coagulation. Top Companion Anim Med. 27:46–52. 2012. View Article : Google Scholar : PubMed/NCBI

11 

de Laforcade A: Diseases associated with thrombosis. Top Companion Anim Med. 27:59–64. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Gando S: Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med. 38(Suppl): S35–S42. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Egorina EM, Sovershaev MA and Hansen JB: The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrinolysis. 22:451–456. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Mackman N: The many faces of tissue factor. J Thromb Haemost. 7(Suppl 1): 136–139. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Schouten M, Wiersinga WJ, Levi M and van der Poll T: Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol. 83:536–545. 2008. View Article : Google Scholar

16 

Bergmann S and Hammerschmidt S: Fibrinolysis and host response in bacterial infections. Thromb Haemost. 98:512–520. 2007.PubMed/NCBI

17 

Hermans PW and Hazelzet JA: Plasminogen activator inhibitor type 1 gene polymorphism and sepsis. Clin Infect Dis. 41(Suppl 7): S453–S458. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Yuan H, Li L, Zheng W, Wan J, Ge P, Li H and Zhang L: Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice. Int Immunopharmacol. 12:682–688. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Silverstein R: D-galactosamine lethality model: Scope and limitations. J Endotoxin Res. 10:147–162. 2004.PubMed/NCBI

20 

Miyazaki M, Kato M, Tanaka M, Tanaka K, Takao S, Kohjima M, Ito T, Enjoji M, Nakamuta M, Kotoh K, et al: Antithrombin III injection via the portal vein suppresses liver damage. World J Gastroenterol. 18:1884–1891. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Takano H, Inoue K, Shimada A, Sato H, Yanagisawa R and Yoshikawa T: Urinary trypsin inhibitor protects against liver injury and coagulation pathway dysregulation induced by lipopolysaccharide/D-galactosamine in mice. Lab Invest. 89:833–839. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Kerr R, Stirling D and Ludlam CA: Interleukin 6 and haemostasis. Br J Haematol. 115:3–12. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Liang DY, Liu LM, Ye CG, Zhao L, Yu FP, Gao DY and Wang YY, Yang ZW and Wang YY: Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-κB pathway in ALF mice. PLoS One. 8:e648952014. View Article : Google Scholar

24 

Jiang R, Wang NP, Tanaka KA, Levy JH, Guyton RA, Zhao ZQ and Vinten-Johansen J: Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways. J Surg Res. 169:319–327. 2011. View Article : Google Scholar

25 

Rhim T, Lee DY and Lee M: Hypoxia as a target for tissue specific gene therapy. J Control Release. 172:484–494. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Ahn JK, Koh EM, Cha HS, Lee YS, Kim J, Bae EK and Ahn KS: Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford). 47:834–839. 2008. View Article : Google Scholar

27 

Bailey CJ and Turner RC: Metformin. N Engl J Med. 334:574–579. 1996. View Article : Google Scholar : PubMed/NCBI

28 

Tsoyi K, Jang HJ, Nizamutdinova IT, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH and Chang KC: Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. Br J Pharmacol. 162:1498–1508. 2011. View Article : Google Scholar :

29 

Hattori Y, Suzuki K, Hattori S and Kasai K: Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension. 47:1183–1188. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Nath N, Khan M, Paintlia MK, Singh I, Hoda MN and Giri S: Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol. 182:8005–8014. 2009. View Article : Google Scholar : PubMed/NCBI

31 

van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Büller HR, et al: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 179:1253–1259. 1994. View Article : Google Scholar : PubMed/NCBI

32 

Wyseure T and Declerck PJ: Novel or expanding current targets in fibrinolysis. Drug Discov Today. 19:1476–1482. 2014. View Article : Google Scholar : PubMed/NCBI

33 

Dupont DM, Madsen JB, Kristensen T, Bodker JS, Blouse GE, Wind T and Andreasen PA: Biochemical properties of plasminogen activator inhibitor-1. Front Biosci (Landmark Ed). 14:1337–1361. 2009. View Article : Google Scholar

34 

Kruithof EK: Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost. 100:969–975. 2008.

35 

Hoesel B and Schmid JA: The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013. View Article : Google Scholar

36 

Lee IT and Yang CM: Inflammatory signalings involved in airway and pulmonary diseases. Mediators Inflamm. 2013:7912312013. View Article : Google Scholar : PubMed/NCBI

37 

Ong SG and Hausenloy DJ: Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacol Ther. 136:69–81. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Brocato J, Chervona Y and Costa M: Molecular responses to hypoxia-inducible factor 1α and beyond. Mol Pharmacol. 85:651–657. 2014. View Article : Google Scholar : PubMed/NCBI

39 

Ramakrishnan P, Hecht BA, Pedersen DR, Lavery MR, Maynard J, Buckwalter JA and Martin JA: Oxidant conditioning protects cartilage from mechanically induced damage. J Orthop Res. 28:914–920. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Levy B: Lactate and shock state: The metabolic view. Curr Opin Crit Care. 12:315–321. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Soric S, Belanger MP, Askin N and Wittnich C: Impact of female sex hormones on liver tissue lactic acidosis during ischemia. Transplantation. 84:763–770. 2007. View Article : Google Scholar : PubMed/NCBI

42 

James JH, Luchette FA, McCarter FD and Fischer JE: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 354:505–508. 1999. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gong X, Duan R, Ao JE, Ai Q, Ge P, Lin L and Zhang L: Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis. Mol Med Rep 12: 6384-6390, 2015.
APA
Gong, X., Duan, R., Ao, J., Ai, Q., Ge, P., Lin, L., & Zhang, L. (2015). Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis. Molecular Medicine Reports, 12, 6384-6390. https://doi.org/10.3892/mmr.2015.4206
MLA
Gong, X., Duan, R., Ao, J., Ai, Q., Ge, P., Lin, L., Zhang, L."Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis". Molecular Medicine Reports 12.4 (2015): 6384-6390.
Chicago
Gong, X., Duan, R., Ao, J., Ai, Q., Ge, P., Lin, L., Zhang, L."Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis". Molecular Medicine Reports 12, no. 4 (2015): 6384-6390. https://doi.org/10.3892/mmr.2015.4206
Copy and paste a formatted citation
x
Spandidos Publications style
Gong X, Duan R, Ao JE, Ai Q, Ge P, Lin L and Zhang L: Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis. Mol Med Rep 12: 6384-6390, 2015.
APA
Gong, X., Duan, R., Ao, J., Ai, Q., Ge, P., Lin, L., & Zhang, L. (2015). Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis. Molecular Medicine Reports, 12, 6384-6390. https://doi.org/10.3892/mmr.2015.4206
MLA
Gong, X., Duan, R., Ao, J., Ai, Q., Ge, P., Lin, L., Zhang, L."Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis". Molecular Medicine Reports 12.4 (2015): 6384-6390.
Chicago
Gong, X., Duan, R., Ao, J., Ai, Q., Ge, P., Lin, L., Zhang, L."Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis". Molecular Medicine Reports 12, no. 4 (2015): 6384-6390. https://doi.org/10.3892/mmr.2015.4206
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team